Latest News

  • Coronavirus SECURE-AD Registry

    The emerging and evolving coronavirus disease 2019 (COVID-19) pandemic has created a global public health emergency1. There is an urgent need to understand the underlying determinants of the outcome of COVID-19 and how this translates to individuals who are treated with immunomodulating medications. This information will be vital for informing assessments of risk of COVID-19 […]

    Read More
  • IEC STATEMENT ON COVID-19

    Dear IEC Friends, In this difficult and uncertain time, IEC would like to provide guidance on the use of systemic treatments for atopic dermatitis (AD; commonly called eczema) in the context of the COVID-19 pandemic, based on currently available pandemic and pharmacologic information. Individuals with AD using immunosuppressive medications should be advised by their physician […]

    Read More
  • IEC Webcasts Available

    Webcasts of IEC symposia on “New Topical Developments and Preventive Mechanisms” and “Atopic Dermatitis Comorbidities” now available on-demand.

    Read More
More Latest News

Upcoming Events & Meetings

More Upcoming Events